Anaemia Drugs, PTV News: May 12, 2010




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Anaemia Drugs, PTV News: May 12, 2010
Released on: May 12, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
Merck & Co halts development of anti-anaemia treatment, giving a boost to Affymax
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Kate Moore
Director
PharmaVentures

Kate has 15 years of experience in the biotechnology industry, most recently as Director of Business Development at TopoTarget. Kate has a successful track record in negotiating in- and out- licensing deals, conducting market evaluations and technical and commercial due diligence. Kate has also held positions in marketing and research at BD Biosciences, BioCarta and Prolifix. Kate has an undergraduate degree from Oxford University and a PhD in Molecular Biology from University College London.
Merck & Co.
Merck & Co., Inc., also known as Merck Sharp & Dohme or MSD outside the United States and Canada, is one of the largest pharmaceutical companies in the world. The headquarters of the company is located in Whitehouse Station, New Jersey, an unincorporated area in Readington Township. It was established in 1891 as the United States subsidiary of the German company now known as Merck KGaA. In common with many other German assets in the United States, Merck & Co. was confiscated in 1917 during World War I and set up as an independent company. It is currently one of the seven largest pharmaceutical companies in the world both by market capitalisation and revenue.

Merck's products cover a broad range of areas, including heart and respiratory health, infectious diseases, sun care and women’s health. And Merck focuses its research on conditions that affect millions of people around the world – diseases like Alzheimer’s, diabetes and cancer – while building strengths in new areas like biologics.
PharmaVentures Ltd
PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:


• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK